Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: One-year results of the essence study
- 30 September 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (3) , 693-698
- https://doi.org/10.1016/s0735-1097(00)00808-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome)Published by Oxford University Press (OUP) ,1999
- Assessment of the Treatment Effect of Enoxaparin for Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial InfarctionCirculation, 1999
- Economic Assessment of Low-Molecular-Weight Heparin (Enoxaparin) Versus Unfractionated Heparin in Acute Coronary Syndrome PatientsCirculation, 1998
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery DiseaseNew England Journal of Medicine, 1997
- Comparison of Low-Molecular-Weight Heparin With Unfractionated Heparin Acutely and With Placebo for 6 Weeks in the Management of Unstable Coronary Artery DiseaseCirculation, 1997
- Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemiaJournal of the American College of Cardiology, 1995
- Persistent activation of coagulation mechanism in unstable angina and myocardial infarction.Circulation, 1994
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992